levothyroxine sodium 0.03 MG/ML Oral Solution [Ermeza]
RxNorm concept 2626056, branded drug (sbd). Prescribable name: Ermeza 150 MCG in 5 mL Oral Solution.
- RxCUI
- 2626056
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626056 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ermeza 0.03 MG/ML Oral Solution; Ermeza 150 MCG per 5 ML Oral Solution; Ermeza 30 MCG per ML Oral Solution
Related concepts
- levothyroxine sodium 0.03 MG/ML (SCDC, consists of)
- levothyroxine sodium 0.03 MG/ML [Ermeza] (SBDC, consists of)
- Oral Solution (DF, has dose form)
- Ermeza (BN, has ingredient)
- levothyroxine sodium 0.03 MG/ML Oral Solution (SCD, tradename of)
Linked data
NDCs
- 49502037815
- 49502037875
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2626056 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626056 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2626056. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.